547.5
-15.05 (-2.68%)
SUDEEPPHRM • 20 Jan, 2026 | 10:59 AM
Sudeep Pharma Stock Performance
|
|
|
Sudeep Pharma Company background
Founded in: 1989
Managing director: Sujit J Bhayani
Sudeep Pharma Limited was incorporated as Sudeep Pharma Private Limited as a private limited company dated December 21, 1989, issued by the Registrar of Companies, Ahmedabad. Thereafter, Company was converted into a public limited company and the name of the Company was changed to Sudeep Pharma Limited pursuant to fresh certificate of incorporation dated April 5, 1995, issued by the Assistant Registrar of Companies, Gujarat at Dadra Nagar Haveli. Company was subsequently converted back to a private limited company vide a fresh certificate of incorporation dated October 1, 2014 issued by the Assistant Registrar of Companies, Gujarat at Ahmedabad, and the name of Company was accordingly changed from Sudeep Pharma Limited to Sudeep Pharma Private Limited. Further, Company was converted into a public limited company and consequently, the name of Company was changed to Sudeep Pharma Limited.The Company is one of the pioneers in India to introduce a product range of liposomal ingredients for nutrient absorption and stability. The Company is a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries. It operate three manufacturing facilities in Vadodara, Gujarat with an annual installed capacity of 65, 579 MT. Since inception in 1989, Company has expanded business operations from production of excipients to a wide variety of over 100 products in the pharmaceutical, food and nutrition industries. Business is primarily structured into two verticals: Pharmaceutical, food and nutrition and Specialty ingredients. The Company focus on providing refined, mineralbased single ingredients essential to the pharmaceutical, food, and nutrition industries.. Many of these minerals act as excipients, supporting the efficacy and stability of pharmaceutical formulations. Specialty ingredients entails production of customized ingredients to improve functionality, stability, and bioavailability across food and nutraceuticalapplications. These specialty ingredients play a key role in enhancing nutritional profiles, texture, and flavour across applications such as fortified dairy, beverages, and bakery products, as well as dietary supplements. Company is planning to launch the initial public offer by raising funds of Rs 95 Crore equity shares through fresh issue and by issuing 10,076,492equity shares, having the face value of Rs 1/ each via offer for sale.
Sudeep Pharma Financial Highlights
For the full year FY2025–2026, revenue
reached ₹511.33 crore and profit touched at
₹138.69 crore. As of Dec '25, Sudeep Pharma’s market capitalisation stood at ₹6,353.93 crores.
Shareholding as of Dec '25 shows promoters holding 76.2%, with FIIs at
1.7%, DIIs at 17.6%, and public at 4.6%.
Sudeep Pharma Share Price Today
As of 20 Jan 2026, Sudeep Pharma share price is ₹547.5. The stock opened at ₹562.4 and had closed at ₹562.6 the previous day. During today’s trading session, Sudeep Pharma share price moved between ₹546.05 and ₹562.45, with an average price for the day of ₹554.25. Over the last 52 weeks, the stock has recorded a low of ₹543.90 and a high of ₹795.00. In terms of performance, Sudeep Pharma share price has declined by 7.7% over the past six months and has declined by 24.25% over the last year.
Sudeep Pharma Fundamental
Market Cap (in crs)
6,353.93
Face Value
1
Turnover (in lacs)
303.12
Key Metrics
Qtr Change %
-7.7
Dividend yield 1yr %
0
Sudeep Pharma Key Financials
View moreLoading chart...
Sudeep Pharma Quarterly Revenue
162.67 Cr | 124.92 Cr |
Sudeep Pharma Yearly Revenue
511.33 Cr | 465.38 Cr | 438.26 Cr |
Sudeep Pharma Quarterly Net Profit/Loss
46.78 Cr | 31.27 Cr |
Sudeep Pharma Yearly Net Profit/Loss
138.69 Cr | 133.19 Cr | 62.32 Cr |
Sudeep Pharma Result Highlights
Result Summary
-
Sudeep Pharma Ltd reported a 32.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Sep (Q2 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a - of -.
-
Its expenses for the quarter were up by 31.7% QoQ and - - YoY.
-
The net profit increased 49.6% QoQ and - - YoY.
-
The earnings per share (EPS) of Sudeep Pharma Ltd stood at 4.2 during Q2 FY 2025-26.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Sudeep Pharma Technical Analysis
Moving Averages Analysis
547.5
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
9
Day EMA5
584.90
Day EMA10
591.60
Day EMA12
594.80
Day EMA20
609.60
Day EMA26
623.30
EMA
EMA
EMA
Delivery & Volume
Loading chart...
Delivery Volume %
Day
37.80%
Week
16.70%
Month
30.40%
Delivery & Volume
Day Rs | 44150 Rs | 116861 Rs |
Week Rs | 109578 Rs | 657449 Rs |
Month Rs | 105617 Rs | 347511 Rs |
Resistance & Support
567.15
Pivot
Resistance
First Resistance
574.30
Second Resistance
586.05
Third Resistance
593.20
Support
First Support
555.40
Second support
548.25
Third Support
536.50
Relative Strength Index
32.53
Money Flow Index
58.10
MACD
-27.25
MACD Signal
-30.29
Average True Range
29.27
Average Directional Index
34.89
Rate of Change (21)
-14.62
Rate of Change (125)
0.00
Sudeep Pharma Peer comparison
Compare384.40 -4.75 (-1.22%)▼ | |
285.40 -4.45 (-1.54%)▼ | |
1,282.40 -12.30 (-0.95%)▼ | |
731.50 -8.60 (-1.16%)▼ | |
768.00 -9.05 (-1.16%)▼ | |
431.20 -6.15 (-1.41%)▼ |
Sudeep Pharma Latest News
Sudeep Pharma Share Price FAQs
Please be aware that Sudeep Pharma stock prices are subject to continuous fluctuations due to various factors.
Invest in Sudeep Pharma
Popular Stocks | |||||||||
47.33 -0.65 (-1.35%)▼ | |||||||||
118.09 -2.81 (-2.32%)▼ | |||||||||
340.45 -3.55 (-1.03%)▼ | |||||||||
2,110.00 -24.60 (-1.15%)▼ | |||||||||
132.25 -2.34 (-1.74%)▼ | |||||||||
325.55 -5.75 (-1.74%)▼ | |||||||||
185.42 -2.85 (-1.51%)▼ | |||||||||
276.15 -5.20 (-1.85%)▼ | |||||||||
414.05 +1.25 (+0.30%)▲ | |||||||||
360.90 -2.30 (-0.63%)▼ | |||||||||
Top Gainers | |||||||||
2,428.40 +14.50 (+0.60%)▲ | |||||||||
344.50 +1.15 (+0.33%)▲ | |||||||||
1,384.30 +3.70 (+0.27%)▲ | |||||||||
942.30 +2.35 (+0.25%)▲ | |||||||||
427.90 +1.00 (+0.23%)▲ | |||||||||
Top Losers | |||||||||
945.80 -23.65 (-2.44%)▼ | |||||||||
420.20 -9.95 (-2.31%)▼ | |||||||||
275.60 -5.75 (-2.04%)▼ | |||||||||
6,996.50 -136.50 (-1.91%)▼ | |||||||||
4,852.50 -89.00 (-1.80%)▼ | |||||||||
Open Demat Account